Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

NCT06623084 is registered in ClinicalTrials.gov with Stefania Basili as lead sponsor.

NCT NCT06623084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06623084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)
Lead sponsor
Stefania Basili
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
December 24, 2025
Enrollment
132 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, control condition, nash - nonalcoholic steatohepatitis, non-alcoholic fatty liver disease (nafld)